Thomas Jefferson University

Lindsay Wilde

TitleFaculty Physician
InstitutionThomas Jefferson University
DepartmentMedical Oncology - Thomas Jefferson University
Address925 Chestnut Street
Philadelphia PA 19107
Phone2159558874
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zeidner JF, Sallman DA, R?cher C, Daver NG, Leung AYH, Hiwase DK, Subklewe M, Pabst T, Montesinos P, Larson RA, Wilde L, Enjeti AK, Kawashima I, Papayannidis C, O'Nions J, Johnson L, Dong M, Huang J, Bagheri T, Hacohen Kleiman G, Lee C, Vyas P. Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study. Blood. 2025 Jul 31; 146(5):590-600. PMID: 40009500.
      Citations:    
    2. Wilde L, Kasner M. Targeting CD47: many misses; hopeful for a hit. Blood. 2025 Jan 30; 145(5):460-462. PMID: 39883445.
      Citations:    
    3. Zimmerman MKA, Wilde L. Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon. Am J Hematol. 2025 Feb; 100(2):298-299. PMID: 39194301.
      Citations:    
    4. Binder AF, Hossain A, Doshi R, Vivero A, Gonzalez KM, Gentsch A, Wilde L, Rising KL. Patient and caregiver perceptions of the possibility of home blood transfusions. Transfusion. 2024 03; 64(3):483-492. PMID: 38263774.
      Citations:    
    5. Palmisiano N, Jeschke G, Wilde L, Alpdogan O, Carabasi M, Filicko-O'Hara J, Grosso D, Klumpp T, Martinez U, Wagner J, Carroll MP, Perl A, Kasner M. A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers (Basel). 2023 Oct 25; 15(21). PMID: 37958304.
      Citations:    
    6. Wilde L, Porazzi P, Trotta R, De Dominici M, Palmisiano N, Keiffer G, Rancani K, Yingling K, Calabretta B, Kasner M. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia. Leuk Res. 2023 06; 129:107075. PMID: 37079999.
      Citations:    
    7. Wilde L, Binder A, Cerchione C, Isidori A. Editorial: COVID-19 and hematological malignancies: Volume II. Front Oncol. 2022; 12:1044582. PMID: 36300086.
      Citations:    
    8. Grosso D, Leiby B, Wilde L, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Mateja G, Alpdogan O, Binder A, Kasner M, Keiffer G, Klumpp T, Martinez UO, Palmisiano N, Porcu P, Gergis U, Flomenberg N. A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation. Transplant Cell Ther. 2022 12; 28(12):831.e1-831.e7. PMID: 36167307.
      Citations:    
    9. Manobianco SA, Rakiewicz T, Wilde L, Palmisiano ND. Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia. Front Oncol. 2022; 12:892289. PMID: 35912243.
      Citations:    
    10. Bi X, French Z, Palmisiano N, Wen KY, Wilde L. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions. Ann Hematol. 2022 Jun; 101(6):1251-1259. PMID: 35288759.
      Citations:    
    11. Binder AF, Loos K, Xu A, Peedin AR, Gergis U, Karp JK, Wilde L. Optimizing Utilization of Blood Products in the Hematologic Malignancy Clinic: Less Is More. JCO Oncol Pract. 2022 06; 18(6):e1016-e1022. PMID: 35192410.
      Citations:    
    12. Wilde L, Kasner M. Whom should we treat with novel agents? Specific indications for specific and challenging populations. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):24-29. PMID: 34889407.
      Citations:    
    13. Wang XA, Binder AF, Gergis U, Wilde L. COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study. Front Oncol. 2021; 11:740320. PMID: 34778057.
      Citations:    
    14. Schmucker AM, Leiby BE, Wilde L. Validation of AML-score in Older Adults Receiving CPX-351 Intensive Induction Chemotherapy for Treatment of Secondary Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2022 03; 22(3):e206-e212. PMID: 34686446.
      Citations:    
    15. Jeurkar C, Wilde L, Leiby BE, Banks J, Kasner M, Keiffer G, Filicko-O'Hara J, Palmisiano N. Inpatient versus outpatient hypomethylating agent induction for acute myeloid leukemia as a predictor for survival. Leuk Res. 2021 04; 103:106533. PMID: 33621825.
      Citations:    
    16. Pan J, Altman D, Wilde L. Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Front Oncol. 2020; 10:576924. PMID: 33194691.
      Citations:    
    17. Keiffer G, French Z, Wilde L, Filicko-O'Hara J, Gergis U, Binder AF. Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia. Front Oncol. 2020; 10:562625. PMID: 33072589.
      Citations:    
    18. Wilde L, Isidori A, Keiffer G, Palmisiano N, Kasner M. Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience. Front Oncol. 2020; 10:1689. PMID: 32984046.
      Citations:    
    19. Wilde L, Ramanathan S, Kasner M. B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia. World J Clin Oncol. 2020 Aug 24; 11(8):528-540. PMID: 32879842.
      Citations:    
    20. Grosso D, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Sun M, Colombe B, Shi W, Werner-Wasik M, Rudolph S, Alpdogan O, Binder A, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wilde L, Porcu P, Gergis U, Flomenberg N. Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes. Biol Blood Marrow Transplant. 2020 10; 26(10):1861-1867. PMID: 32629157.
      Citations:    
    21. Binder AF, Handley NR, Wilde L, Palmisiano N, Lopez AM. Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care. Front Oncol. 2020; 10:1183. PMID: 32676459.
      Citations:    
    22. Kim RS, Yaghy A, Wilde LR, Shields CL. An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor. JAMA Ophthalmol. 2020 04 01; 138(4):418-419. PMID: 32163103.
      Citations:    
    23. Wilde L, Pan J. Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and Beyond. Clin Lymphoma Myeloma Leuk. 2019 12; 19(12):758-762. PMID: 31678078.
      Citations:    
    24. Wilde L, Cooper J, Wang ZX, Liu J. Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML). Front Oncol. 2019; 9:1016. PMID: 31681569.
      Citations:    
    25. McBride A, Houtmann S, Wilde L, Vigil C, Eischen CM, Kasner M, Palmisiano N. The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome. Front Oncol. 2019; 9:192. PMID: 30972300.
      Citations:    
    26. Wilde L, Tanson K, Curry J, Martinez-Outschoorn U. Autophagy in cancer: a complex relationship. Biochem J. 2018 06 11; 475(11):1939-1954. PMID: 29891531.
      Citations:    
    27. Hannon M, Wilde L, Nwaoduah N, Kasner M. Chronic myelomonocytic leukemia with central nervous system involvement. Leuk Lymphoma. 2018 09; 59(9):2267-2268. PMID: 29322838.
      Citations:    
    28. Wilde L, Mehrotra P, Hoffman-Censits J. Recurrent renal cell carcinoma presenting as a solitary left ventricular mass. Can J Urol. 2017 Dec; 24(6):9145-9147. PMID: 29260644.
      Citations:    
    29. Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, Martinez-Outschoorn U. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol. 2017 06; 44(3):198-203. PMID: 29248131.
      Citations:    
    30. Wilde L, Ali SM, Solomides CC, Ross JS, Trabulsi E, Hoffman-Censits J. Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature. Clin Genitourin Cancer. 2017 06; 15(3):e521-e524. PMID: 28143711.
      Citations:    
    31. Hoffman-Censits J, Wilde L. Combination immunotherapy in genitourinary malignancies. Curr Opin Urol. 2016 11; 26(6):523-8. PMID: 27517637.
      Citations:    
    32. Wilde L, Worster B, Oxman D. Monthly "Grief Rounds" to Improve Residents' Experience and Decrease Burnout in a Medical Intensive Care Unit Rotation. Am J Med Qual. 2016 Jul; 31(4):379. PMID: 27259873.
      Citations:    
    Wilde's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (122)
    Explore
    _
    Co-Authors (34)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _